Lillo, Rosa
Graziani, Francesca
Franceschi, Francesco
Iannaccone, Giulia
Massetti, Massimo
Olivotto, Iacopo
Crea, Filippo
Liuzzo, Giovanna
Funding for this research was provided by:
Università Cattolica del Sacro Cuore
Article History
Accepted: 26 March 2023
First Online: 28 April 2023
Declarations
:
: Not applicable.
: Francesca Graziani has received grants from Takeda and Pfizer; she has received honoraria for board meetings and travel support from Amicus Therapeutics, Sanofi-Genzyme, and Shire. Iacopo Olivotto has received grants from Myokardia, Sanofi Genzyme, Shire, Bayer, Amicus, and Menarini International; he has received board and/or speaker’s fees from Myokardia, Cytokinetics, Sanofi Genzyme, and Shire. Rosa Lillo has received honoraria for board meetings and travel support from Amicus Therapeutics, Sanofi-Genzyme, and Shire. The remaining authors declare no competing interests.